CBD oil sales will rise through 2036, driven by hemp oil at 71.0% share of the product type segment in 2026. Pharmaceuticals account for 36.0% share by application and indirect B2C channels hold 73.0% share in 2026. Sales are likely to be valued at USD 1.05 billion in 2026 and USD 15.60 billion by 2036.